Atopic Dermatitis: Targeting Underlying Inflammatory Pathways with Systemic Therapy. This activity is sponsored by Sanofi Genzyme and Regeneron Pharmaceuticals.

“The Non-CME Corporate Forum content and views expressed therein do not necessarily reflect the views, policies or position of the American College of Allergy, Asthma & Immunology.”


Thursday, November 4, 2021

6:30PM – 7:00PM CT: Registration and Dinner
7:00PM – 8:30PM CT: Symposium

Hilton New Orleans Riverside
2 Poydras St
New Orleans, LA 70130
Meeting Room: Grand Ballroom A

Program Features

  • iPads provided to all attendees to enhance learning experience and enable real-time Q&A
  • Create your own personalized poster
  • Interactive case-based learning environment
  • Animated Simulation Treatment Challenges


Donald Y M Leung, PhD, MD
Professor and Division Head
Pediatric Allergy & Immunology
Department of Pediatrics
National Jewish Health
Denver, CO

Peter A Lio, MD
Clinical Assistant Professor
Dermatology and Pediatrics
Northwestern University Feinberg School of Medicine
Medical Dermatology Associates of Chicago
Chicago, IL

Learning Objectives

After completing this activity, learners should be better able to:

  • Apply up-to-date guidance on the initiation and use of systemic immunosuppressants and immunomodulators in patients with atopic dermatitis during the COVID-19 pandemic
  • Assess the severity of atopic dermatitis and select appropriate treatment options for patients who require intensified therapy
  • Review the mechanism of action, efficacy and safety of systemic treatments for atopic dermatitis in pediatric and adult patients

Target Audience

 This activity is intended for allergists, immunologists, and other healthcare professionals involved in the management of patients with atopic dermatitis.


Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.